5,538
Views
8
CrossRef citations to date
0
Altmetric
Articles

Clinical value of the Montreal Cognitive Assessment (MoCA) in patients suspected of cognitive impairment in old age psychiatry. Using the MoCA for triaging to a memory clinic

ORCID Icon, & ORCID Icon
Pages 1-17 | Received 20 May 2020, Accepted 06 Nov 2020, Published online: 03 Dec 2020

References

  • Alzheimer’s Disease International. (2016). World Alzheimer Report 2016 – Improving healthcare for people living with dementia coverage, quality and costs now and in the future. About the report. http://www.alz.co.uk
  • Alzheimer’s Disease International. (2018). From plan to impact progress towards targets of the global action plan on dementia. https://www.alz.co.uk/adi/pdf/from-plan-to-impact-2018.pdf
  • American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (Revised 4th ed.).
  • Baune, B. T., & Renger, L. (2014). Pharmacological and non-pharmacological interventions to improve cognitive dysfunction and functional ability in clinical depression—a systematic review. Psychiatry Research, 219(1), 25–50. https://doi.org/10.1016/j.psychres.2014.05.013
  • Blair, M., Coleman, K., Jesso, S., Desbeaumes Jodoin, V., Smolewska, K., Warriner, E., Finger, E., & Pasternak, S. H. (2016). Depressive symptoms negatively impact Montreal Cognitive Assessment performance: A memory clinic experience. Canadian Journal of Neurological Sciences, 43(4), 513–517. https://doi.org/10.1017/cjn.2015.399
  • Borson, S., Frank, L., Bayley, P. J., Boustani, M., Dean, M., Lin, P. J., McCarten, J. R., Morris, J. C., Salmon, D. P., Schmitt, F. A., Stefanacci, R. G., Mendiondo, M. S., Peschin, S., Hall, E. J., Fillit, H., & Ashford, J. W. (2013). Improving dementia care: The role of screening and detection of cognitive impairment. Alzheimer’s and Dementia, 9(2), 151–159. https://doi.org/10.1016/j.jalz.2012.08.008
  • Brunet, M. D., McCartney, M., Heath, I., Tomlinson, J., Gordon, P., Cosgrove, J., Deveson, P., Gordon, S., Marciano, S. A., Colvin, D., Sayer, M., Silverman, R., & Bhattia, N. (2013). There is no evidence base for proposed dementia screening. BMJ (Online), 346(7889). https://doi.org/10.1136/bmj.e8588
  • Burn, A. M., Fleming, J., Brayne, C., Fox, C., & Bunn, F. (2018). Dementia case-finding in hospitals: A qualitative study exploring the views of healthcare professionals in English primary care and secondary care. BMJ Open, 8(3), e020521. https://doi.org/10.1136/bmjopen-2017-020521
  • Carson, N., Leach, L., & Murphy, K. J. (2018). A re-examination of Montreal Cognitive Assessment (MoCA) cutoff scores. International Journal of Geriatric Psychiatry, 33(2), 379–388. https://doi.org/10.1002/gps.4756
  • Cordell, C. B., Borson, S., Boustani, M., Chodosh, J., Reuben, D., Verghese, J., Thies, W., & Fried, L. B. (2013). Alzheimer’s Association recommendations for operationalizing the detection of cognitive impairment during the Medicare Annual Wellness visit in a primary care setting. Alzheimer’s and Dementia, 9(2), 141–150. https://doi.org/10.1016/j.jalz.2012.09.011
  • Dautzenberg, G., Lijmer, J., & Beekman, A. (2020). Diagnostic accuracy of the Montreal Cognitive Assessment (MoCA) for cognitive screening in old age psychiatry: Determining cutoff scores in clinical practice. Avoiding spectrum bias caused by healthy controls. International Journal of Geriatric Psychiatry, 35(3), 261–269. https://doi.org/10.1002/gps.5227
  • Davis, D. H. J., Creavin, S. T., Noel-Storr, A., Quinn, T. J., Smailagic, N., Hyde, C., Brayne, C., Mcshane, R., & Cullum, S. (2013). Neuropsychological tests for the diagnosis of Alzheimer’s disease dementia and other dementias: A generic protocol for cross-sectional and delayed-verification studies. Cochrane Database of Systematic Reviews, 2013(3). https://doi.org/10.1002/14651858.CD010460
  • Davis, D. H. J., Creavin, S. T., Yip, J. L. Y., Noel-Storr, A. H., Brayne, C., & Cullum, S. (2015). Montreal Cognitive Assessment for the diagnosis of Alzheimer’s disease and other dementias. Cochrane Database of Systematic Reviews, 2015(10). https://doi.org/10.1002/14651858.CD010775.pub2
  • Elkana, O., Tal, N., Oren, N., Soffer, S., & Ash, E. L. (2020). Is the cutoff of the MoCA too high? Longitudinal data from highly educated older adults. Journal of Geriatric Psychiatry and Neurology, 33(3), 155–160. https://doi.org/10.1177/0891988719874121
  • Fischer, J. E., Bachmann, L. M., & Jaeschke, R. (2003). A readers’ guide to the interpretation of diagnostic test properties: Clinical example of sepsis. Intensive Care Medicine, 29(7), 1043–1051. https://doi.org/10.1007/s00134-003-1761-8
  • Gauthier, S., Reisberg, B., Zaudig, M., Petersen, R. C., Ritchie, K., Broich, K., Belleville, S., Brodaty, H., Bennett, D., Chertkow, H., Cummings, J. L., de Leon, M., Feldman, H., Ganguli, M., Hampel, H., Scheltens, P., Tierney, M. C., Whitehouse, P., & Winblad, B. (2006). Mild cognitive impairment. Lancet, 367(9518), 1262–1270. https://doi.org/10.1016/S0140-6736(06)68542-5
  • Gil, L., De Sánchez, R., Gil, C., Romero, F., J, S., & Pretelt Burgos, F. (2015). Validation of the Montreal Cognitive Assessment (MoCA) in Spanish as a screening tool for mild cognitive impairment and mild dementia in patients over 65 years old in Bogotá, Colombia. International Journal of Geriatric Psychiatry, 30(6), 655–662. https://doi.org/10.1002/gps.4199
  • Gorelick, P. B., Scuteri, A., Black, S. E., Decarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., Petersen, R. C., Schneider, J. A., Tzourio, C., Arnett, D. K., Bennett, D. A., Chui, H. C., Higashida, R. T., Lindquist, R., Nilsson, P. M., … Seshadri, S. (2011). Vascular contributions to cognitive impairment and dementia: A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 42(9), 2672–2713. https://doi.org/10.1161/STR.0b013e3182299496
  • Gorno-Tempini, M. L., Hillis, A. E., Weintraub, S., Kertesz, A., Mendez, M., Cappa, S. F., Ogar, J. M., Rohrer, J. D., Black, S., Boeve, B. F., Manes, F., Dronkers, N. F., Vandenberghe, R., Rascovsky, K., Patterson, K., Miller, B. L., Knopman, D. S., Hodges, J. R., Mesulam, M. M., & Grossman, M. (2011). Classification of primary progressive aphasia and its variants. Neurology, 76(11), 1006–1014. https://doi.org/10.1212/WNL.0b013e31821103e6
  • Grimmer, T., Beringer, S., Kehl, V., Alexopoulos, P., Busche, A., Förstl, H., Goldhardt, O., Natale, B., Ortner, M., Peters, H., Riedl, L., Roßmeier, C., Valentin, W., Diehl-Schmid, J., & Kurz, A. (2015). Trends of patient referral to a memory clinic and towards earlier diagnosis from 1985–2009. International Psychogeriatrics, 27(12), 1939–1944. https://doi.org/10.1017/S104161021500157X
  • Janssen, J., Koekkoek, P. S., Biessels, G.-J., Kappelle, J. L., Rutten, G. E. H. M., & Cog-ID Study Group. (2019). Depressive symptoms and quality of life after screening for cognitive impairment in patients with type 2 diabetes: Observations from the Cog-ID cohort study. BMJ Open, 9(1), e024696. https://doi.org/10.1136/bmjopen-2018-024696
  • Janssen, J., Koekkoek, P. S., Van Charante, M., Jaap Kappelle, E. P., Biessels, L., & Rutten, G. J., & M, G. E. H. (2017). How to choose the most appropriate cognitive test to evaluate cognitive complaints in primary care. BMC Family Practice, 18(1), 101. https://doi.org/10.1186/s12875-017-0675-4
  • Larner, A. J. (2012). Screening utility of the Montreal Cognitive Assessment (MoCA): In place of—or as well as—the MMSE? International Psychogeriatrics, 24(3), 391–396. https://doi.org/10.1017/S1041610211001839
  • Le Couteur, D. G., Doust, J., Creasey, H., & Brayne, C. (2013). Political drive to screen for pre-dementia: Not evidence based and ignores the harms of diagnosis. BMJ (Online), 347(7925), f5125. https://doi.org/10.1136/bmj.f5125
  • Lee, J. Y., Lee, D. W., Cho, S. J., Na, D. L., Jeon, H. J., Kim, S. K., Lee, Y. R., Youn, J. H., Kwon, M., Lee, J. H., & Cho, M. J. (2008). Brief screening for mild cognitive impairment in elderly outpatient clinic: Validation of the Korean version of the Montreal Cognitive Assessment. Journal of Geriatric Psychiatry and Neurology, 21(2), 104–110. https://doi.org/10.1177/0891988708316855
  • Lin, J. S., O’Connor, E., Rossom, R. C., Perdue, L. A., & Eckstrom, E. (2013). Screening for cognitive Impairment in older adults: A systematic review for the U. S. Preventive Services Task Force. Annals of Internal Medicine, 159(9), 601–612. https://doi.org/10.7326/0003-4819-159-9-201311050-00730
  • McCarten, J. R., Anderson, P., Kuskowski, M. A., McPherson, S. E., & Borson, S. (2011). Screening for cognitive impairment in an elderly veteran population: Acceptability and results using different versions of the Mini-Cog. Journal of the American Geriatrics Society, 59(2), 309–313. https://doi.org/10.1111/j.1532-5415.2010.03249.x
  • McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O’Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., Aarsland, D., Arai, H., Ballard, C. G., Boeve, B., Burn, D. J., Costa, D., Del Ser, T., Dubois, B., Galasko, D., … Consortium on DLB. (2005). Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium. Neurology, 65(12), 1863–1872. https://doi.org/10.1212/01.wnl.0000187889.17253.b1
  • McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., Mohs, R. C., Morris, J. C., Rossor, M. N., Scheltens, P., Carrillo, M. C., Thies, B., Weintraub, S., & Phelps, C. H. (2011). The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s & Dementia : The Journal of the Alzheimer’s Association, 7(3), 263–269. https://doi.org/10.1016/j.jalz.2011.03.005
  • mocatest.org. (n.d.). Retrieved December 31, 2019, from https://www.mocatest.org/
  • Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J. L., & Chertkow, H. (2005). The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society, 53(4), 695–699. https://doi.org/10.1111/j.1532-5415.2005.53221.x
  • Neary, D., Brun, A., Englund, B., Gustafson, L., Passant, U., Mann, D. M. A., & Snowden, J. S. (1994). Clinical and neuropathological criteria for frontotemporal dementia. Journal of Neurology, Neurosurgery and Psychiatry, 57(4), 416–418. https://doi.org/10.1136/jnnp.57.4.416
  • Nederlandse Vereniging voor Klinische Geriatrie. (2014). Richtlijn “Diagnostiek en medicamenteuze behandeling van dementie”. CBO. https://www.nvvp.net/stream/richtlijn-diagnostiek-en-behandeling-van-dementie-2014
  • Noel-Storr, A. H., McCleery, J. M., Richard, E., Ritchie, C. W., Flicker, L., Cullum, S. J., Davis, D., Quinn, T. J., Hyde, C., Rutjes, A. W. S., Smailagic, N., Marcus, S., Black, S., Blennow, K., Brayne, C., Fiorivanti, M., Johnson, J. K., Köpke, S., Schneider, L. S., … McShane, R. (2014). Reporting standards for studies of diagnostic test accuracy in dementia: The STARDdem Initiative. Neurology, 83(4), 364–373. https://doi.org/10.1212/WNL.0000000000000621
  • O’Caoimh, R., Timmons, S., & Molloy, D. W. (2016). Screening for mild cognitive impairment: Comparison of “MCI specific” screening instruments. Journal of Alzheimer’s Disease, 51(2), 619–629. https://doi.org/10.3233/JAD-150881
  • Pendlebury, S. T., Klaus, S. P., Mather, M., de Brito, M., & Wharton, R. M. (2015). Routine cognitive screening in older patients admitted to acute medicine: Abbreviated Mental Test Score (AMTS) and subjective memory complaint versus Montreal Cognitive Assessment and IQCODE. Age and Ageing, 44(6), 1000–1005. https://doi.org/10.1093/ageing/afv134
  • Pugh, E. A., Kemp, E. C., van Dyck, C. H., Mecca, A. P., & Sharp, E. S. (2018). Effects of normative adjustments to the Montreal Cognitive Assessment. American Journal of Geriatric Psychiatry, 26(12), 1258–1267. https://doi.org/10.1016/j.jagp.2018.09.009
  • Ramírez, L. R. B., Saracco-Álvarez, R., Escamilla-Orozco, R., & Orellana, A. F. (2014). Validez de la escala de evaluación cognitiva de montreal (MoCA) para determinar deterioro cognitivo en pacientes con esquizofrenia. Salud Mental, 37(6), 517–522. https://doi.org/10.17711/sm.0185-3325.2014.062
  • Reisberg, B., Ferris, S. H., De Leon, M. J., & Crook, T. (1982). The global deterioration scale for assessment of primary degenerative dementia. American Journal of Psychiatry, 139(9), 1136–1139. https://doi.org/10.1176/ajp.139.9.1136
  • Román, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J. M., Brun, A., Hofman, A., Moody, D. M., O’Brien, M. D., Yamaguchi, T., Grafman, J., Drayer, B. P., Bennett, D. A., Fisher, M., Ogata, J., Kokmen, E., … Scheinberg, P. (1993). Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology, 43(2), 250–260. https://doi.org/10.1212/WNL.43.2.250
  • Rossetti, H. C., Lacritz, L. H., Munro Cullum, C., & Weiner, M. F. (2011). Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample. Neurology, 77(13), 1272–1275. https://doi.org/10.1212/WNL.0b013e318230208a
  • Smith, T., Gildeh, N., & Holmes, C. (2007). The Montreal Cognitive Assessment: Validity and utility in a memory clinic setting. Canadian Journal of Psychiatry, 52(5), 329–332. https://doi.org/10.1177/070674370705200508
  • Verhey, F. R. J., Ramakers, I. H. G. B., Bouwens, S. F. M., Blom, M., Scheltend, P., Vernooij-Dassen, M., & Olde Rikkert, M. (2010). Geheugenpoli monitor 2009. https://server12.np.unimaas.nl/mhens/div1/monitor/geheugenpolimonitor_2009.pdf
  • Waldron-Perrine, B., & Axelrod, B. N. (2012). Determining an appropriate cutting score for indication of impairment on the Montreal Cognitive Assessment. International Journal of Geriatric Psychiatry, 27(11), 1189–1194. https://doi.org/10.1002/gps.3768
  • Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. O., Nordberg, A., Bäckman, L., Albert, M., Almkvist, O., Arai, H., Basun, H., Blennow, K., De Leon, M., Decarli, C., Erkinjuntti, T., Giacobini, E., Graff, C., Hardy, J., … Petersen, R. C. (2004). Mild cognitive impairment –beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment. Journal of Internal Medicine, 256(3), 240–246. https://doi.org/10.1111/j.1365-2796.2004.01380.x
  • Wu, C., Dagg, P., & Molgat, C. (2017). Measuring stability of cognitive impairment in inpatients with schizophrenia with alternate forms of the Montreal Cognitive Assessment during acute hospitalization. Psychiatry Research, 258, 299–304. https://doi.org/10.1016/j.psychres.2017.08.065
  • Yesavage, J. A., & Sheikh, J. I. (1986). Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version. Clinical Gerontologist, 5(1–2), 165–173. https://doi.org/10.1300/J018v05n01_09
  • Yoon, S., Shin, C., & Han, C. (2017). Depression and cognitive function in mild cognitive impairment: A 1-year follow-up study. Journal of Geriatric Psychiatry and Neurology, 30(5), 280–288. https://doi.org/10.1177/0891988717723741